Fong Clow

30 papers receiving 1.2k citations

Fong Clow's Hit Papers

Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial 2018 · 386 citations
3860+2+5Years since publication100200300

Peers

Fong Clow
Comparison fields: 5 of 64
  • Genetics 794
  • Pathology and Forensic Medicine 699
  • Hematology 306
  • Immunology 244
  • Gastroenterology 50
Replace Florence Cymbalista with:
Florence Cymbalista France
Jae‐Cheol Jo South Korea
Thomas E. Lew Australia
Toshiyuki Ohno Japan
AG Bosanquet United Kingdom
Phuong Dang Australia
Lucy S. Hodge United States
Roberto Foà Italy
Lydia Wunderle Germany
Agnès Guerci France
Fong Clow relative to Florence Cymbalista France Florence Cymbalista's profile →
Citations per field
00.5×1.5×
Florence Cymbalista · 1×
Citations per year

Countries citing papers authored by Fong Clow

Since Specialization
Citations

This map shows the geographic impact of Fong Clow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fong Clow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fong Clow more than expected).

Fields of papers citing papers by Fong Clow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fong Clow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fong Clow. The network helps show where Fong Clow may publish in the future.

Co-authors

The 25 scholars most cited alongside Fong Clow, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Fong Clow Line = papers co-authored together Fong Clow links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial
Hit paper breakdown →
2018386
2 2007235
3 201793
4 201591
5 201973
6 201653
7 201244
8 201340
9 201832
10 201831
11 201530
12 202422
13 201520
14 201219
15 20149
16 20138
17 20138
18 20148
19 20068
20 20157

About Fong Clow

Fong Clow is a scholar working on Genetics, Pathology and Forensic Medicine, Hematology, Gastroenterology and Public Health, Environmental and Occupational Health, having authored 30 papers that have together received 1.3k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (26 papers), Lymphoma Diagnosis and Treatment (17 papers), Chronic Myeloid Leukemia Treatments (10 papers), Gastrointestinal Tumor Research and Treatment (5 papers), Acute Lymphoblastic Leukemia research (3 papers), Immunodeficiency and Autoimmune Disorders (3 papers), Multiple Myeloma Research and Treatments (3 papers) and Prostate Cancer Treatment and Research (2 papers). The work is most often cited by research in Genetics (794 citations), Pathology and Forensic Medicine (699 citations), Hematology (306 citations), Immunology (244 citations) and Gastroenterology (50 citations). Fong Clow has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Danelle F. James, Ian W. Flinn, Lori Styles, Cathy Zhou, Susan O’Brien, Bertrand Anz, Loree Larratt, Richard Greil, Jan Novák and Olga Samoilova. Their work appears in journals such as Blood, Journal of Clinical Oncology, British Journal of Haematology, Biology of Blood and Marrow Transplantation and Clinical Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact